tm logo
MOLECULARLIFE
REGISTERED

on 11 May 2018

Last Applicant/ Owned by

MOLECULAR HEALTH GMBH

Kurfürsten-Anlage 2169115 Heidelberg

DE

Serial Number

1729546 filed on 22nd May 2015

Registration Number

TMA996456 registered on 11th May 2018

Registration expiry Date

11th May 2033

Correspondent Address

213-304 Old Canmore RoadCanmore

ALBERTA

CA

T1W0L5

MOLECULARLIFE

Trademark usage description

diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely cancer; biologic Read More

Classification Information


Class [005]
Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely cancer; biological and medical preparations and articles, in particular diagnostic reagents for medical diagnostic use, reagents for analyzing biological samples, in particular genomic DNA, and diagnostic biomarker reagents for medical diagnostic use.


Classification kind code

10

Class [009]
Downloadable computer databases containing information in the field of genomics, cancer research and cancer treatments; downloadable mobile software applications for access to information in the field of genomics, cancer research and cancer treatment; computer databases, in particular biomedical computer databases containing information about clinical, molecular, scientific and patient specific data, in particular information that clinicians and researchers enable to interpret complex molecular patient information, biomedical information in form of human genome sequences, indication and disease classifications, biomarkers, information about the molecular mechanism of action of drugs, drug-to-drug interactions, information about scientific publications from diverse areas of biomedicine, in particular for the integration, interpretation and analysis of cancer genomic information; computer software for authorizing access to these biomedical databases, in particular application software, interface software, software drives, data communication software, interactive computer software, computer software for applications on mobile devices, in particular mobile computers, smartphones, tablets, laptops, wearables; analytical software and software components for serving domain-specific user demands, in particular for the assistance of cancer treatment decisions and the provision of consumer-friendly reports.


Classification kind code

10

Class [044]
Medical testing for diagnostic and treatment purposes; genetic testing for medical purposes; consulting services in the field of diagnostic medical testing; health care consulting in the field of cancer treatment; providing online information, via the internet and mobile applications, in the fields of genetic testing and cancer diagnosis and treatment; medical and pharmaceutical consulting services relating to patient specific medical treatment options, in particular cancer treatment options; medical consulting services relating to the treatment and diagnosis of individuals, in particular in the fields of genetic analysis, clinical pharmacology, dosage regimes and dose-effect relationships; providing pharmaceutical and medical information, in particular information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individuals; medical consulting services in the fields of patient treatment and treatment protocols, diagnostic molecular testing, drug safety, dosage assessment, in particular in the field of cancer treatment therapy for others.


Classification kind code

10

Mark Details


Serial Number

1729546

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 50
on 25th Nov 2016
Allowed
Submitted for opposition 51
on 25th Nov 2016
Allowance Notice Sent
Submitted for opposition 42
on 10th Aug 2016
Advertised
Submitted for opposition 26
on 21st Jul 2016
Approved
Submitted for opposition 27
on 31st May 2016
Approval Notice Sent
Submitted for opposition 22
on 26th Nov 2015
Search Recorded
Submitted for opposition 20
on 26th Nov 2015
Examiner's First Report
Submitted for opposition 31
on 01st Jun 2015
Formalized
Submitted for opposition 1
on 25th May 2015
Created
Submitted for opposition 30
on 22nd May 2015
Filed